Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean G Tang

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
RNA Biology|October 1, 2021
Inhibition of CDK9 activity compromises global splicing in prostate cancer cellsQiang Hu, Ninu Poulose, Samuel Girmay, et al.
Plos One|September 22, 2011
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanismsHong Yan, Xin Chen, Qiuping Zhang, et al.
Cancer Letters|September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapyQinju He, Yuanzhen Zhang, Wenchao Li, et al.
The Journal of Pathology|June 8, 2018
Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancerTae Gyu Choi, Minh Nam Nguyen, Jieun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2016
Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate CancerXin Chen, Qiuhui Li, Xin Liu, et al.
Nature Communications|March 1, 2016
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancerDingxiao Zhang, Daechan Park, Yi Zhong, et al.
Nature Medicine|January 18, 2011
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Can Liu, Kevin Kelnar, Bigang Liu, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promisesWen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
International Journal of Molecular Sciences|February 24, 2024
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and PromisesWen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypesAnmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
RNA Biology|October 1, 2021
Inhibition of CDK9 activity compromises global splicing in prostate cancer cellsQiang Hu, Ninu Poulose, Samuel Girmay, et al.
Plos One|September 22, 2011
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanismsHong Yan, Xin Chen, Qiuping Zhang, et al.
Cancer Letters|September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapyQinju He, Yuanzhen Zhang, Wenchao Li, et al.
The Journal of Pathology|June 8, 2018
Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancerTae Gyu Choi, Minh Nam Nguyen, Jieun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2016
Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate CancerXin Chen, Qiuhui Li, Xin Liu, et al.
Nature Communications|March 1, 2016
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancerDingxiao Zhang, Daechan Park, Yi Zhong, et al.
Nature Medicine|January 18, 2011
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Can Liu, Kevin Kelnar, Bigang Liu, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promisesWen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
International Journal of Molecular Sciences|February 24, 2024
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and PromisesWen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypesAnmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.
Pageof 14